A novel antibody targeting TIM-3 resulting in receptor internalization for cancer immunotherapy
{{output}}
Background: Strategies to reinvigorate exhausted T cells have achieved great efficacy in certain subpopulations of tumor patients. Blocking the antibodies that target programmed cell death protein 1 (PD-1) and cytotoxic T-lymphoc... ...
